Shamsideen Musa, MD
Anesthesiology · Anchorage, AKNPI 1649616459
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Medtronic at 52.5% of the total. Reporting peaked in 2022 at $10,195 and has fallen 68.6% since, to $3,206 in 2025. Among anesthesiology clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $104.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Abbott$4K
- Boston Scientific$3K
- Globus Medical$2K
- Vertos Medical, Inc.$1K
- Genesys Orthopedics Systems, L.L.C.$1K
- plus $5K from 29 others
What the payments were for
- Speaking & faculty fees$6752%
- Travel & lodging$21,30758%
- Food & beverage$14,41940%
- Education$630%
- Gifts$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 142 | $19,165 |
| Abbott | 53 | $4,261 |
| Boston Scientific | 25 | $3,382 |
| Globus Medical | 22 | $2,109 |
| Vertos Medical, Inc. | 6 | $1,254 |
| Genesys Orthopedics Systems, L.L.C. | 4 | $1,223 |
| Nevro Corp. | 23 | $963 |
| Protega Pharmaceutials Inc | 2 | $713 |
| AbbVie(2 entities) | 16 | $605 |
| Neuronetics, Inc. | 9 | $586 |
| Richard Wolf Medical Instruments Corp. | 2 | $411 |
| Relievant Medsystems, Inc. | 4 | $191 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $179 |
| AstraZeneca | 4 | $140 |
| Redhill Biopharma Inc. | 1 | $125 |
| Foundation Fusion Solutions, LLC | 1 | $124 |
| Pacira Therapeutics, Inc. | 1 | $122 |
| Pfizer | 5 | $117 |
| Painteq LLC | 1 | $112 |
| Baudax Bio Inc. | 1 | $109 |
| Bioventus LLC | 2 | $83 |
| Amgen | 3 | $82 |
| SPR Therapeutics, Inc | 1 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Tonix Medicines, Inc. | 1 | $35 |
| Spinal Simplicity, LLC | 1 | $35 |
| GRT US Holding, Inc. | 2 | $34 |
| Si-bone, Inc. | 2 | $33 |
| Stimwave Technologies Incorporated | 1 | $30 |
| Braeburn Inc. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| GSK | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$4,671
- VANTA ADAPTIVESTIM$3,127
- SYNCHROMEDII$3,059
- SPECTRA WAVEWRITER$2,836
- PROCLAIM$2,795
- SYNCHROMED$2,056
- Senza$1,834
- ADAPTIVESTIM$1,594
- SI Joint$1,200
- KYPHON EXPRESS II KYPHOPAK TRAY$1,124
- mild Device Kit$1,121
- Spine Endoscopy$411
- Intracept$305
- ETERNA$288
- INCEPTIV$287
- VRAYLAR$227
- Accurian$226
- MOVANTIK$125
- Zilretta$122
- Senza Spinal Cord Stimulation System$119
How this compares
$36,475 in reported general payments places this provider in the 95th percentile of 101 anesthesiology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 15 | $15,343 |
| Xtampza ErOxycodone Myristate | 13 | $9,730 |
| Oxycodone Hcl | 145 | $3,179 |
| Lidocaine | 43 | $2,526 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $2,413 |
| Celecoxib | 15 | $1,628 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $1,605 |
| Gabapentin | 81 | $1,325 |
| Tramadol Hcl | 38 | $1,030 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $928 |
| Morphine Sulfate ErMorphine Sulfate | 37 | $717 |
| Pregabalin | 55 | $716 |
| Diclofenac Sodium | 25 | $485 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $426 |
| Morphine Sulfate | 13 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $605 | $15,34315 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $24 | $9,73013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 101 anesthesiology providers in Alaska.
Other anesthesiology in Anchorage
- Alfred LonserAnchorage$16K
- Heath McAnallyAnchorage$1K
- Jann UrbanAnchorage$748
- Minhe KimAnchorage$424
- Anne WanaseljaAnchorage$283
- Sundrayah StollerAnchorage$281
- Pamela ToddAnchorage$222
- Mary LanzaAnchorage$207
- Colby ParksAnchorage$180
- Mark RainosekAnchorage$179
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.